* If you want to update the article please login/register
Several research have investigated the effects of anthropometric risk factors on metabolic syndrome. However, no systematic study has investigated the effect of overweight and obesity on the incidence of metabolic syndrome in India. We therefore performed a meta-analysis to determine the effect of anthropometric risk factors on metabolic syndrome prevalence. We used the Newcastle-Ottawa scale to determine the accuracy of published research, conducted a meta-analysis with a random-effects model, and reported pooled odds ratios with 95% CIs. Analysis We reviewed 26 studies with a total number of 37,965 participants. Participants who were overweight or obese had a higher risk of experiencing metabolic syndrome than those with normal or low body mass. Conclusions Overweight and obesity are both strongly related to metabolic syndrome. Clinicians and policy makers should implement weight reduction plans among patients and the general population, based on evidence.
Source link: https://europepmc.org/article/MED/35512304
Background: Although many research has been done on laughter's psychological benefits, few have investigated both the psychological and physical consequences. This paper looks at the effects of a laughter program on body weight, body mass index, subjective anxiety, and health-related quality of life among Japanese community-dwelling people using a random controlled trial with a waitlist. Methods Overall, 235 participants aged 43-79 years were selected into laughter intervention and control groups and then enrolled in a 12-week laughter group. According to these findings, exercise and enhancing HRQOL and mental health, such as subjective well-being and optimism, may help reduce body weight in participants with metabolic syndrome risk factors by lowering stress and improving HRQOL and mental health indicators, such as subjective well-being and optimism. Trial registration Registered with the University Hospital Medical Information Network Clinical Trials Registry Registration Number 27/04/2017: UMIN-CTR000027145, 27/04/2017.
Source link: https://europepmc.org/article/MED/35461239
Pomegranate is a multipurpose medicinal and dietary plant thanks to its anti-inflammatory and antioxidant properties. Pomegranate can be used to prevent or treat metabolic syndrome risk factors. Although earlier published studies focused on the effects of pomegranate on various diseases, there is no systematic study that solely focuses on clinical trials related to all MetS-related risk factors. The aim of this up-to-date, comprehensive, and systematic review is to critically assess the risk of pomegranate on various MetS risk factors based on clinical findings. According to the Cochrane Handbook on Systematic Reviews of Interventions, the Preferred Reporting Items for a Systematic Review and Meta-Analysis recommendations were followed, and the bias risk analysis was performed. According to the included studies, pomegranate can be useful in reducing body weight, blood pressure, glycemia, triglycerides, total cholesterol, and low-density lipoprotein cholesterol.
Source link: https://europepmc.org/article/MED/35458227
Among emerging adults, the relationship between CRF and adiposity with cardiometabolic risk factors and metabolic syndrome was investigated. 5681 college students from a large university located in the northeast of the United States' northeast. Participants: 581 college students from a large university located in the northeast. Conclusions: Poor CRF and elevated adiposity were both related to cardiovascular risk factors and metabolic syndrome, regardless of sex, with the connection between adiposity and risk factors reported to be greater than CRF.
Source link: https://europepmc.org/article/MED/35380927
Obesity in the upper body has been shown to be correlated with metabolic syndrome and an elevated risk of cardiovascular disease. In the ethnic population of Sikkim, this current study is being conducted with the aim of determining the connection of neck circumference with metabolic syndrome. Neck circumference was determined to be statistically significant in metabolic syndrome by the 56. 6 percent subject with metabolic syndrome, with elevated triglyceride levels the most commonly found. Patients with a larger neck circumference should be screened for cardiovascular risk factors.
Source link: https://europepmc.org/article/MED/35443471
Background Many patients with acute coronary syndrome have concurrent metabolic risk factors that increase the risk of major adverse cardiovascular events. According to baseline cardiovascular risk factors, we wanted to investigate the effects of the PCSK9 inhibitor alirocumab on MACE in comparison to placebo on MACE. Methods We conducted a post-hoc review of the ODYSSEY OUTCOMES trial, a multicentre, double-blind, randomised controlled trial conducted in 1315 hospitals and outpatient clinics in 57 countries. Patients were randomly assigned to 75 mg alirocumab by subcutaneous injection every 2 weeks or match placebo, beginning 1-12 months after acute coronary syndrome and lasting for a median of 28 years. MACE risk and the effect of alirocumab were determined according to the number of metabolic risk factors. Alirocumab reduced the relative risk of MACE among categories outlined by the number of metabolic risk factors, but absolute risk reduction increased with the number of metabolic risk factors. The prevalence of MACE in patients with no metabolic risk factors increased from 76% in those with no metabolic risk factors to 43 percent in those with five variables. Acccumulation of metabolic risk factors in patients with recent acute coronary syndrome was associated with a higher risk of MACE.
Source link: https://europepmc.org/article/MED/35378068
The definition of metabolic syndrome can vary from one to another guideline and health institution. As MetS, a description of global health services, the occurrence of hyperinsulinemia or hyperglycemia in addition to two or three other causes of dyslipidemia, hypothalphalipoproteinemia, hypertension, or other significant waist circumference factors would be included as MetS. In several experimental in-vitro, in-vivo, and clinical settings, fish peptide-rich marines, made a significant bioactive presence in different experimental in-vitro, in-vivo, and clinical settings. This review exclusively focuses on studies from the last decade that investigated hypoglycemic, hypolipidemic, hypercholesterolemic, and anti-obesogenic fish and fish peptides. Only for comparison purposes are reviews of anti-MetS fish biopeptide extraction, isolation, and purification methods. Moreover, the development and discovery of anti-MetS compounds has been examined in detail, as well as the improvement of biopeptides in simulated gastrointestinal environment and structure-activity relationship along with absorption, distribution, metabolism, and excretion characteristics of selected oligopeptides in a brief period.
Source link: https://europepmc.org/article/MED/35297701
Using the Korea National Health and Nutrition Examination Survey, we investigated liver enzyme reference values based on cardiometabolic risks among children and adolescents using the Korea National Health and Nutrition Examination Survey. AST levels tend to decline with age, but ALT levels had a U-shaped curve, resulting in a gradual rise in the AST/ALT ratio after age 13. Liver enzymes were also involved in the rise in the adjusted mean values for each risk factor for MetS.
Source link: https://europepmc.org/article/PPR/PPR468884
In Tehranian adults, we wanted to investigate the connection between the two factors of established lifestyle habits, expressed as a healthy lifestyle score, and the risk of MetS. Participants of the Tehran Lipid and Glucose Study were recruited from among other participants of the Tehran Lipid and Glucose Study's 6 years of observation. MetS had a mean of 3480 participants. At baseline, dietary data were obtained using a validated food frequency questionnaire at baseline. In the age and sex adjusted model, there was no correlation between the higher score of HLSAHEI2010, HLS, and HLSHDP with MetS' risk. MetS' risk decreased across tertiles of HLS, and HDP in the multivariable model after accounting for confounding factors. The results of the new study show that greater adherence to modifiable health status factors scores is linked to a reduced risk of MetS.
Source link: https://europepmc.org/article/MED/IND607676894
Background Individuals with metabolic syndrome have a higher risk of experiencing atherosclerosis cardiovascular disease than those without MetS are at a higher risk of experiencing atherosclerotic cardiovascular disease than those without MetS, due to persistent endothelial dysfunction, dyslipidemia, and insulin resistance. HIFT's effects on dyslipidemia and endothelial dysfunction have yet to be investigated, nor have the effects been investigated in a population with MetS. In addition, no studies have looked at the minimal dose of HIFT per week to see clinically meaningful improvements in cardiometabolic health. The aim of this research was to determine the dose-response effect of HIFT on blood lipids, insulin resistance, and endothelial function, as well as determine the dose-response effect of HIFT on body composition, endurance, and motivations to continue exercising. If an accurate dose of HIFT per week is found and if this modality is perceived positively, it could give exercise professionals and health care providers a tool to prevent and treat MetS.
Source link: https://europepmc.org/article/MED/35232475
* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions